Records containing: Myotonic Dystrophy Type 1
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-23A Global Phase 3 Open-Label Extension Study to Assess the Long-Term Safety, Tolerability, and Efficacy of Intravenous AOC 1001 for the Treatment of Myotonic Dystrophy Type 1
-
CLINICAL_TRIALS study record update · 2026-03-25Determination of Fall Frequency and Factors Affecting Dynamic Balance in Patients With Myotonic Dystrophy Type 1: A Cross-Sectional Observational Single-Center Study
-
CLINICAL_TRIALS study record update · 2026-02-19Music Intervention for Brain-Heart Disease in Myotonic Dystrophy Type 1 (DM1)
-
CLINICAL_TRIALS study record update · 2026-02-04Creación de un Nodo Integral Para la Distrofia Miotónica Tipo 1 en España: Registro clínico, Mapas genómicos, epigenómicos y proteómicos (DM1-Hub)
-
CLINICAL_TRIALS study record update · 2026-02-02Brain Structure and Clinical Endpoints in Myotonic Dystrophy Type 2 (BraCE-DM2)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-11-24Cerebrospinal Fluid Biomarkers of Myotonic Dystrophy
-
CLINICAL_TRIALS study record update · 2025-10-15National Registry of Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Patients and Family Members
-
CLINICAL_TRIALS study record update · 2025-02-24Pelvic Floor Muscle Training for Urinary Incontinence in Women with Myotonic Dystrophy Type 1: a Feasibility and Acceptability Study
-
CLINICAL_TRIALS study record update · 2024-09-19Efficacy of Wheelchair Skills Training to Improve Mobility for People with ARSACS and DM1
-
CLINICAL_TRIALS study record update · 2023-12-01Virtual Reality-training in Theory of Mind in the Childhood Form of Myotonic Dystrophy Type 1
-
CLINICAL_TRIALS study record update · 2022-12-06A Phase 1/2a Blinded, Placebo-Controlled Study to Assess the Safety, Tolerability, and Dose-range Finding of Multiple Ascending Doses of ISIS 598769 Administered Subcutaneously to Adult Patients With Myotonic Dystrophy Type 1
-
CLINICAL_TRIALS study record update · 2022-01-06A Placebo Controlled, Randomized, Double-Blind Phase II Clinical Trial to Evaluate Tolerability, Safety and Efficacy Endpoints After Administration of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) for 24 Weeks in Adults With Myotonic Dystrophy Type 1
-
CLINICAL_TRIALS study record update · 2021-04-13Myotonic Dystrophy Type 1 (DM1) Deep Phenotyping to Improve Delivery of Personalized Medicine and Assist in the Planning, Design and Recruitment of Clinical Trials
-
CLINICAL_TRIALS study record update · 2017-10-26A Multicenter Observational Study to Assess the Variability of Molecular Biomarkers and Clinical Measures in Patients With Myotonic Dystrophy Type 1
-
CLINICAL_TRIALS study record update · 2017-07-18Observational Prolonged Trial in Myotonic Dystrophy Type 1 to Improve Quality of Life Standards, a Target Identification Collaboration
-
CLINICAL_TRIALS study record update · 2014-10-21Defining and Managing the Neuropsychological Abnormalities of Myotonic Dystrophy